Years after Texas backed off HPV vaccine mandate, cervical cancer rate soars

Twelve years after Texas and Australia veered onto wildly different courses regarding HPV prevention, their gap in health outcomes has widened demonstrably.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news

Related Links:

Up to one in seven five-year-olds may not be up to date with MMR Related items fromOnMedica Swine flu jab in pregnancy safe for children as well as mothers Parental confidence in immunisation programme ‘very high’ Debate over mandatory MMR vaccination Preventing cervical cancer: how a screening switch and HPV vaccination should cut cancer rates Experts profile four types of vaccine refusers
Source: OnMedica Latest News - Category: UK Health Source Type: news
For its first few years on the market, the human papillomavirus (HPV) vaccine was approved only for young girls. Over time, the U.S. Food and Drug Administration (FDA) has broadened its approval to include boys, as well as adults up to age 45—allowing more people to get the cancer-preventing vaccine, but also breeding confusion about who should get vaccinated and when. On Thursday, the U.S. Centers for Disease Control and Prevention (CDC) released new recommendations, based on guidance from the Advisory Committee on Immunization Practices, that should clear up some of that confusion. The CDC reaffirmed that its prior...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized onetime public health Source Type: news
Abstract The conventional prophylactic vaccines for human papillomavirus (HPV) efficiently prevent infection with high-risk HPV types, but they do not promote therapeutic effects against cervical cancer. Previously, we developed HPV16 E7-expressing Lactobacillus casei (L. casei-E7) as a therapeutic vaccine candidate for cervical cancer, which induces antitumor therapeutic effects in a TC-1 murine cancer model. To improve the therapeutic effect of L. casei-E7, we performed co-treatment with poly-gamma-glutamic acid (γ-PGA), a safe and edible biomaterial naturally secreted by Bacillus subtilis. We investigated...
Source: Journal of Microbiology and Biotechnology - Category: Biotechnology Authors: Tags: J Microbiol Biotechnol Source Type: research
irc; Abstract Cervical cancer is the fourth most common cancer among women worldwide and its development is mainly associated with human papillomavirus infection, a highly sexually transmissible virus. The expression of E6 and E7 viral oncoproteins deregulates cell repairing mechanisms through impairment of tumor suppressor protein functions, such as p53 or retinoblastoma protein. Although the implementation of new preventive vaccines has decreased the infection rate and cervical cancer progression, there are still many women who are affected by this pathology. Nowadays, the main treatment often requires the use o...
Source: Drug Discovery Today - Category: Drugs & Pharmacology Authors: Tags: Drug Discov Today Source Type: research
Publication date: December 2019Source: Current Opinion in Virology, Volume 39Author(s): Silvia de Sanjose, Maria Brotons, D Scott LaMontagne, Laia BruniSince 2006, 115 countries and territories have introduced human papillomavirus (HPV) vaccination programs.Several efforts have been undertaken to evaluate the impact of HPV vaccines. Many countries, mainly high-income and with high screening coverage, are already reporting a visible impact of the HPV vaccine on HPV-related diseases. Others, largely low-income and middle-income countries, are introducing HPV vaccine to control HPV diseases that will undoubtedly generate a si...
Source: Current Opinion in Virology - Category: Virology Source Type: research
The Johns Hopkins University researcher's work helped solidify the link between human papillomavirus and cervical cancer, leading to the approval of the HPV vaccine in 2006.
Source: The Scientist - Category: Science Tags: News & Opinion Source Type: news
Persistent infection with human papillomavirus (HPV) initiates ~5% of all human cancers, and particularly cervical and oropharyngeal cancers. HPV vaccines prevent HPV infection, but do not eliminate existing HPV infections. Papillomaviruses induce hyperproliferation of epithelial cells. In this review we discuss how hyperproliferation renders epithelial cells less sensitive to immune attack, and impacts upon the efficiency of the local immune system. These observations have significance for the design of therapeutic HPV cancer immunotherapies.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
In Mozambique cervical cancer is a public health threat, due to its high incidence and limited access to early diagnosis of precancerous lesions. International organisations are supporting the introduction of ...
Source: BMC Public Health - Category: Consumer Health News Authors: Tags: Research article Source Type: research
ConclusionsThe small number of studies identified from LMICs is of concern as these countries face the largest burden of disease related to HPV. This scoping overview also found and excluded a number of reviews because of important methodological limitations, highlighting the need for future reviews to use appropriate methods. The overview indicates areas in which further primary studies are needed on HPV vaccination communication in LMICs.Systematic review registrationOpen Science Frameworkhttps://osf.io/agzb4/
Source: Systematic Reviews - Category: International Medicine & Public Health Source Type: research
A single dose of the human papillomavirus (HPV) vaccine seems to be almost as good as two or three injections for preventing cervical precancerous lesions
Source: New Scientist - Health - Category: Consumer Health News Source Type: research
More News: Australia Health | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Health | Vaccines